| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJHF.798 |
| P698 | PubMed publication ID | 28295985 |
| P50 | author | Hans-Peter Brunner-La Rocca | Q67186593 |
| P2093 | author name string | Matthias Pfisterer | |
| Kaatje Goetschalckx | |||
| Micha T Maeder | |||
| Alain Bernheim | |||
| Peter Rickenbacher | |||
| Beat A Kaufmann | |||
| Otmar Pfister | |||
| TIME-CHF Investigators | |||
| P2860 | cites work | 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q29620107 |
| The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. | Q33984662 | ||
| Spironolactone for heart failure with preserved ejection fraction | Q34414462 | ||
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib | Q34677347 | ||
| Irbesartan in patients with heart failure and preserved ejection fraction | Q34877640 | ||
| Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction | Q36573602 | ||
| Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions | Q36667022 | ||
| Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. | Q37082859 | ||
| Heart failure with preserved ejection fraction: a clinical dilemma | Q38195149 | ||
| Risk prediction in patients with heart failure: a systematic review and analysis | Q38246491 | ||
| BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial | Q38383948 | ||
| The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial | Q38437264 | ||
| Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction | Q39146347 | ||
| N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME | Q39227748 | ||
| Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study | Q44418516 | ||
| Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Q44588075 | ||
| Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry | Q46135201 | ||
| Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients | Q46837803 | ||
| Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes | Q47731353 | ||
| How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure? | Q48381763 | ||
| Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). | Q48564136 | ||
| Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden | Q78652027 | ||
| The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%) | Q85290915 | ||
| Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging | Q86455840 | ||
| Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction | Q86543015 | ||
| Implications of coronary artery disease in heart failure with preserved ejection fraction | Q87759719 | ||
| P433 | issue | 12 | |
| P921 | main subject | heart failure | Q181754 |
| ejection fraction | Q641303 | ||
| congestive heart failure | Q19000661 | ||
| P304 | page(s) | 1586-1596 | |
| P577 | publication date | 2017-03-15 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). | |
| P478 | volume | 19 |
| Q64911105 | Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis. |
| Q93059808 | Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China |
| Q47186244 | Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain). |
| Q89720376 | December 2017 at a glance: left ventricular ejection fraction, exercise capacity, peripartum cardiomyopathy |
| Q92307253 | Drug therapy in elderly heart failure patients |
| Q90418281 | Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40 |
| Q91540428 | Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction |
| Q46846141 | Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. |
| Q91958702 | Heart Failure with Mid-Range Ejection Fraction - State of the Art |
| Q89071677 | Heart Failure with Mid-Range Ejection Fraction and How to Treat It |
| Q58804692 | Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM |
| Q52608229 | Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies. |
| Q56962646 | Heart failure with mid-range ejection fraction and with preserved ejection fraction |
| Q50068685 | Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum |
| Q49833975 | Heart failure with mid-range ejection fraction: a transition phenotype? |
| Q50040940 | Heart failure with mid-range ejection fraction: causes and consequences |
| Q91578785 | Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry® |
| Q90841019 | Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines |
| Q93046014 | Highlights in heart failure |
| Q94487073 | Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study |
| Q92105646 | Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction |
| Q46178786 | Predictors and outcomes of heart failure with mid-range ejection fraction |
| Q90650423 | Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction |
| Q90299460 | The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction |
| Q64924769 | The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis. |
| Q92684923 | Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019 |
| Q50079611 | What have we learned about heart failure with mid-range ejection fraction one year after its introduction? |
| Q88993030 | [Update on heart failure] |
Search more.